“Patenting Diagnostics: Going Back to the Drawing Board,” Pharmaceutical Executive

Daniel Reisner, Partner in the Intellectual Property group, authored the article “Patenting Diagnostics: Going Back to the Drawing Board” in the August 1, 2010, issue of Pharmaceutical Executive. The article discusses a number of court cases in the US that raise uncertainty regarding the patentability and protection of new and emerging technologies, such as diagnostic methods. It highlights the Supreme Court decision in Bilski v. Kappos, and the implications of this and other decisions for the pharmaceutical and technology industries.